Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Sign in
Join now
Guru Sonpavde MD
Guru P. Sonpavde MD Advisory Board
Jean-Yves Douillard MD, PhD
Jean-Yves Douillard MD, PhD Advisory Board
Roxana Dronca MD
Roxana S. Dronca MD Advisory Board
See All Experts
Published in Oncology

News · September 17, 2024

ESMO 2024: Survival Maintained With Chemotherapy-Free Tx for Metastatic Breast Cancer

Addition of ribociclib to trastuzumab and pertuzumab may further improve survival in HER2-positive and hormone receptor-positive breast cancer

PracticeUpdate Editorial Team

 

 Save  Recommend
 Share

Further Reading

Most Read This Week

Recently Updated